MA53900A - Nouveaux dérivés d'amino-pyrimidonyl-pipéridinyl, leur procédé de préparation et compositions pharmaceutiques les contenant - Google Patents
Nouveaux dérivés d'amino-pyrimidonyl-pipéridinyl, leur procédé de préparation et compositions pharmaceutiques les contenantInfo
- Publication number
- MA53900A MA53900A MA053900A MA53900A MA53900A MA 53900 A MA53900 A MA 53900A MA 053900 A MA053900 A MA 053900A MA 53900 A MA53900 A MA 53900A MA 53900 A MA53900 A MA 53900A
- Authority
- MA
- Morocco
- Prior art keywords
- pyrimidonyl
- preparation
- pharmaceutical compositions
- compositions containing
- new amino
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/07—Optical isomers
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18306377 | 2018-10-19 | ||
| EP19305936 | 2019-07-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA53900A true MA53900A (fr) | 2022-01-26 |
Family
ID=68234009
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA053900A MA53900A (fr) | 2018-10-19 | 2019-10-18 | Nouveaux dérivés d'amino-pyrimidonyl-pipéridinyl, leur procédé de préparation et compositions pharmaceutiques les contenant |
Country Status (24)
| Country | Link |
|---|---|
| US (1) | US20210355106A1 (fr) |
| EP (1) | EP3866930A1 (fr) |
| JP (1) | JP2022505122A (fr) |
| KR (1) | KR20210081371A (fr) |
| CN (1) | CN113038990A (fr) |
| AU (1) | AU2019360391A1 (fr) |
| BR (1) | BR112021006714A2 (fr) |
| CA (1) | CA3116089A1 (fr) |
| CL (1) | CL2021000973A1 (fr) |
| CO (1) | CO2021004553A2 (fr) |
| CR (1) | CR20210173A (fr) |
| DO (1) | DOP2021000063A (fr) |
| EC (1) | ECSP21024078A (fr) |
| IL (1) | IL282218A (fr) |
| JO (1) | JOP20210063A1 (fr) |
| MA (1) | MA53900A (fr) |
| MX (1) | MX2021004379A (fr) |
| NI (1) | NI202100024A (fr) |
| PE (1) | PE20211649A1 (fr) |
| PH (1) | PH12021550788A1 (fr) |
| SG (1) | SG11202103279RA (fr) |
| TW (1) | TW202028188A (fr) |
| UY (1) | UY38423A (fr) |
| WO (1) | WO2020079205A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CR20220294A (es) | 2019-12-20 | 2022-08-03 | Bayer Ag | Tiofenocarboxamidas sustituidas y sus derivados |
| CN114507163A (zh) * | 2020-11-16 | 2022-05-17 | 尚科生物医药（上海）有限公司 | 一种制备2-氟-5-甲氧基苯磺酰氯的方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR3052452B1 (fr) * | 2016-06-10 | 2018-06-22 | Les Laboratoires Servier | Nouveaux derives de piperidinyle, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
| PE20220948A1 (es) * | 2016-06-10 | 2022-05-31 | Servier Lab | Nuevos derivados piperidinilo sustituidos con (hetero) arilo, un proceso para su preparacion y composiciones farmaceuticas que los contienen |
| GB201617758D0 (en) * | 2016-10-20 | 2016-12-07 | Almac Discovery Limited | Pharmaceutical compounds |
-
2019
- 2019-10-17 UY UY0001038423A patent/UY38423A/es unknown
- 2019-10-18 BR BR112021006714-0A patent/BR112021006714A2/pt unknown
- 2019-10-18 JP JP2021521034A patent/JP2022505122A/ja active Pending
- 2019-10-18 CA CA3116089A patent/CA3116089A1/fr active Pending
- 2019-10-18 JO JOP/2021/0063A patent/JOP20210063A1/ar unknown
- 2019-10-18 KR KR1020217014709A patent/KR20210081371A/ko unknown
- 2019-10-18 PE PE2021000517A patent/PE20211649A1/es unknown
- 2019-10-18 MA MA053900A patent/MA53900A/fr unknown
- 2019-10-18 TW TW108137746A patent/TW202028188A/zh unknown
- 2019-10-18 MX MX2021004379A patent/MX2021004379A/es unknown
- 2019-10-18 CN CN201980074282.0A patent/CN113038990A/zh active Pending
- 2019-10-18 SG SG11202103279RA patent/SG11202103279RA/en unknown
- 2019-10-18 US US17/282,898 patent/US20210355106A1/en active Pending
- 2019-10-18 CR CR20210173A patent/CR20210173A/es unknown
- 2019-10-18 AU AU2019360391A patent/AU2019360391A1/en not_active Abandoned
- 2019-10-18 WO PCT/EP2019/078318 patent/WO2020079205A1/fr active Application Filing
- 2019-10-18 EP EP19786808.6A patent/EP3866930A1/fr not_active Withdrawn
-
2021
- 2021-04-07 EC ECSENADI202124078A patent/ECSP21024078A/es unknown
- 2021-04-09 PH PH12021550788A patent/PH12021550788A1/en unknown
- 2021-04-09 DO DO2021000063A patent/DOP2021000063A/es unknown
- 2021-04-09 NI NI202100024A patent/NI202100024A/es unknown
- 2021-04-11 IL IL282218A patent/IL282218A/en unknown
- 2021-04-12 CO CONC2021/0004553A patent/CO2021004553A2/es unknown
- 2021-04-16 CL CL2021000973A patent/CL2021000973A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| PH12021550788A1 (en) | 2021-10-18 |
| CO2021004553A2 (es) | 2021-04-30 |
| CL2021000973A1 (es) | 2021-11-19 |
| KR20210081371A (ko) | 2021-07-01 |
| WO2020079205A1 (fr) | 2020-04-23 |
| EP3866930A1 (fr) | 2021-08-25 |
| UY38423A (es) | 2021-02-26 |
| IL282218A (en) | 2021-05-31 |
| PE20211649A1 (es) | 2021-08-24 |
| CR20210173A (es) | 2021-05-11 |
| ECSP21024078A (es) | 2021-05-31 |
| JOP20210063A1 (ar) | 2023-01-30 |
| NI202100024A (es) | 2021-08-24 |
| DOP2021000063A (es) | 2021-08-31 |
| TW202028188A (zh) | 2020-08-01 |
| CA3116089A1 (fr) | 2020-04-23 |
| BR112021006714A2 (pt) | 2021-07-27 |
| SG11202103279RA (en) | 2021-04-29 |
| AU2019360391A1 (en) | 2021-05-13 |
| CN113038990A (zh) | 2021-06-25 |
| US20210355106A1 (en) | 2021-11-18 |
| MX2021004379A (es) | 2021-06-04 |
| JP2022505122A (ja) | 2022-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA42231A (fr) | Nouveaux dérivés d'hydroxyacide, leur procédé de préparation, et compositions pharmaceutiques les contenant | |
| MA42232B1 (fr) | Nouveaux dérivés d'acide aminé, leur procédé de préparation et compositions pharmaceutiques les contenant | |
| MA42239B1 (fr) | Nouveaux dérivés d'hydroxyester, leur procédé de préparation et compositions pharmaceutiques les contenant | |
| FR3046792B1 (fr) | Nouveaux derives d'ammonium, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| MA45223B1 (fr) | Nouveaux dérivés de pipéridinyle subsitués par (hétéro)aryle, leur procédé de préparation et compositions pharmaceutiques les contenant | |
| MA42230B1 (fr) | Dérivés bicycliques, leur procédé de préparation, et compositions pharmaceutiques les contenant | |
| MA45222B1 (fr) | Nouveaux dérivés de pipéridinyle, procédé de préparation de ceux-ci et compositions pharmaceutiques les contenant | |
| MA37206B1 (fr) | Nouveaux derives de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| MA38803A1 (fr) | Nouveaux dérivés d'indolizine, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent | |
| BR112021025928A2 (pt) | Métodos de preparação de ácido bempedoico e composições do mesmo | |
| FR2986002A1 (fr) | Nouveaux derives d'indolizine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| MA37213B1 (fr) | Nouveaux derives phosphates, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| MA53900A (fr) | Nouveaux dérivés d'amino-pyrimidonyl-pipéridinyl, leur procédé de préparation et compositions pharmaceutiques les contenant | |
| MA50450B1 (fr) | Nouveaux derives macrocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| FR2907451B1 (fr) | "nouveaux derives indoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent" | |
| MA53088A (fr) | Dérivés d'amino-pyrimidonyle, procédé de préparation de ceux-ci et compositions pharmaceutiques les contenant | |
| MA54379A (fr) | Nouvelles formes cristallines d'un inhibiteur mcl-1, procédé de préparation associé et compositions pharmaceutiques les contenant | |
| FR2854634B1 (fr) | Nouveaux derives de thiadiazine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| MA27070A1 (fr) | Nouveaux derives de l'isoquinoleine, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| FR2874923B1 (fr) | Application a titre de medicaments de derives du 3, 5-seco-4-nor-cholestane, compositions pharmaceutiques les renfermant, nouveaux derives et leur procede de preparation | |
| FR2870538B1 (fr) | Nouveaux derives de pyrrolidines et de thiazolidines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| TN2018000226A1 (fr) | Nouveaux derives de phosphinanes et azaphosphinanes, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| FR2907452B1 (fr) | "nouveaux derives indoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent" | |
| FR2918370B1 (fr) | Nouveaux derives naphtaleniques,leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
| DZ3040A1 (fr) | Benzolactames et thioamides cycliques substitués nouveaux, procédé pour préparation et compositions pharmaceutiques les contenant. |